Ioannides C G, Itoh K, Fox F E, Pahwa R, Good R A, Platsoucas C D
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4244-8. doi: 10.1073/pnas.84.12.4244.
We developed a monoclonal antibody (mAb) (9D7) against a synthetic peptide (P13K) selected from the deduced amino acid sequence of the constant region of the gamma chain of the murine T-cell antigen receptor (TCR) (amino acids 118-130). Using this mAb, we identified a putative second TCR expressed on peripheral blood lymphocytes from a patient with severe combined immunodeficiency (SCID) that were propagated in culture with recombinant interleukin 2 (rIL-2) and Con A. This mAb immunoprecipitated two polypeptide chains of 40 and 58 kDa under nonreducing conditions and of 40 and 56 kDa under reducing conditions from 125I-labeled denatured lysates of T3+ WT31- lymphocytes expanded in culture from a SCID patient. These polypeptide chains were not disulfide linked and were not present on human peripheral blood lymphocytes from normal donors cultured for 5 days with phytohemagglutinin or for 2 weeks with rIL-2 and polyclonal activators or on cells of the Jurkat lymphoblastoid human T-cell line. Chemical crosslinking of 125I-labeled cells followed by immunoprecipitation with anti-Leu-4 mAb under nonreducing or reducing conditions revealed that the 40- and 56-kDa polypeptide chains were associated with the T3 differentiation antigen. These results were confirmed by sequential immunoprecipitation with anti-Leu-4 mAb followed by 9D7 anti-P13K mAb. The 9D7 anti-P13K mAb immunoprecipitated two polypeptide chains of 43 and 64 kDa from denatured lysates of lymphocytes from a patient with severe common variable immunodeficiency (CVI) that were expanded in culture with rIL-2 and Con A. Thus, this second TCR may be composed of two polypeptide chains (gamma gamma'), both of which appear to be the product of the gamma-chain gene. These experiments were done with polyclonal cell populations. Cloned T3+ WT31- cell populations are required to determine whether this TCR contains two gamma polypeptide chains. In contrast, only one polypeptide chain of 56 kDa was immunoprecipitated by the 9D7 anti-P13K mAb from peripheral blood lymphocytes from a patient with mild CVI expanded in culture with rIL-2 and polyclonal activators. Using the same 9D7 anti-P13K mAb and immunoblotting analysis, we identified a 35 kDa gamma-chain polypeptide under reducing conditions expressed on purified L3T4- Lyt2- BALB/c mouse thymocytes. This gamma-chain TCR is disulfide linked and has a molecular mass of 80 kDa under nonreducing conditions.
我们针对从小鼠T细胞抗原受体(TCR)γ链恒定区推导的氨基酸序列中选择的合成肽(P13K)(氨基酸118 - 130)开发了一种单克隆抗体(mAb)(9D7)。利用这种mAb,我们在一名重症联合免疫缺陷(SCID)患者外周血淋巴细胞上鉴定出一种假定的第二种TCR,这些淋巴细胞在重组白细胞介素2(rIL - 2)和刀豆蛋白A(Con A)存在的情况下进行培养扩增。在非还原条件下,这种mAb从一名SCID患者培养扩增的T3 + WT31 - 淋巴细胞的125I标记变性裂解物中免疫沉淀出两条分子量分别为40 kDa和58 kDa的多肽链,在还原条件下则为40 kDa和56 kDa。这些多肽链不是通过二硫键连接的,并且在正常供体的人外周血淋巴细胞中不存在,这些淋巴细胞用植物血凝素培养5天,或用rIL - 2和多克隆激活剂培养2周,也不存在于Jurkat淋巴母细胞样人T细胞系的细胞上。对125I标记的细胞进行化学交联,然后在非还原或还原条件下用抗Leu - 4 mAb进行免疫沉淀,结果显示40 kDa和56 kDa的多肽链与T3分化抗原相关。这些结果通过先用抗Leu - 4 mAb进行顺序免疫沉淀,然后用9D7抗P13K mAb进行免疫沉淀得到了证实。9D7抗P13K mAb从一名重症常见可变免疫缺陷(CVI)患者培养扩增的淋巴细胞变性裂解物中免疫沉淀出两条分子量分别为43 kDa和64 kDa的多肽链,这些淋巴细胞在rIL - 2和Con A存在的情况下进行培养扩增。因此,这种第二种TCR可能由两条多肽链(γγ')组成,这两条链似乎都是γ链基因的产物。这些实验是用多克隆细胞群体进行的。需要克隆的T3 + WT31 - 细胞群体来确定这种TCR是否包含两条γ多肽链。相比之下,9D7抗P13K mAb从一名轻度CVI患者培养扩增的外周血淋巴细胞中仅免疫沉淀出一条56 kDa的多肽链,这些淋巴细胞在rIL - 2和多克隆激活剂存在的情况下进行培养扩增。使用相同的9D7抗P13K mAb和免疫印迹分析,我们在还原条件下在纯化的L3T4 - Lyt2 - BALB/c小鼠胸腺细胞上鉴定出一条35 kDa的γ链多肽。这种γ链TCR是通过二硫键连接的,在非还原条件下分子量为80 kDa。